1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On August 31, 2026, FingerMotion issued 3,958,055 common shares at $0.24 each and pre-funded warrants for 12,708,611 shares in a registered direct offering, netting about $4.0 million after offering expenses. The company also ended its at-the-market sales agreement with R.F. Lafferty & Co., Inc., originally dated October 23, 2025. The sale adds shares and potential shares to the count, which dilutes existing shareholders, and the proceeds are earmarked for general corporate and working capital purposes.
Issued 3,958,055 common shares at $0.24 per share on August 31, 2026
Sold pre-funded warrants for 12,708,611 shares; each warrant priced at $0.2399 with a $0.0001 exercise price
Netted approximately $4.0 million after estimated offering expenses, for general corporate and working capital purposes
Terminated at-the-market sales agreement with R.F. Lafferty & Co., Inc., originally dated October 23, 2025
Inflection Point Acquisition Corp. VIII, a blank-check company (ticker IPHX), closed its initial public offering on August 31, 2026, selling 28,750,000 units at $10.00 per unit for gross proceeds of $287.5 million. The full $287.5 million was placed in a U.S.-based trust account, and the company has 24 months from the closing to complete a business combination, or it must redeem public shares.
IPO closed August 31, 2026: 28,750,000 units at $10.00 each, including 3,750,000 units from the underwriters' full over-allotment option.
Private placement of 8,000,000 warrants at $1.00 each, for $8,000,000 in gross proceeds: the sponsor, Inflection Point Holdings VIII LLC, bought 5,000,000 and Cohen & Company Capital Markets bought 3,000,000.
$287,500,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
Transaction costs totaled $19,545,458, including a $13,687,500 deferred underwriting fee.
Matthews International entered a Ninth Amendment to its credit agreement on September 1, 2026, aligning the facility with its structure after recent divestitures. The revolving credit facility shrinks to $650 million from $700 million, a Foreign Borrower sub-limit falls from $350 million to $0.00, and the Company gets temporary covenant relief tied to its 40% Propelis Joint Venture interest through December 31, 2027.
Revolving credit facility reduced to $650 million from $700 million
Matthews Europe GmbH released from the Credit Agreement; Foreign Borrower limit cut to $0.00 from $350 million
Covenant Relief Period runs through December 31, 2027; maximum Leverage Ratio of 5.25 to 1.00 for quarters ending September 30, 2026 through June 30, 2027
Leverage Ratio steps down to 4.50 to 1.00 after the relief period ends; 0.50 reduction applies if Propelis is sold
On September 1, 2026, Air T and eight subsidiaries entered Amendment No. 7 to their Alerus credit agreement. The amendment raises the revolving commitment from $20.0 million to $25.0 million, ends a temporary overline commitment, and sets the revolver's termination date at August 27, 2029. For shareholders, the filing shows a larger committed credit line and new loan terms, including a 5.00 percentage point interest rate increase upon an event of default.
Revolving commitment rises from $20.0 million to $25.0 million, with a termination date of August 27, 2029.
A $11.46 million Consolidated Term Note combines Term Loan A, Term Loan C and overline loans, with final principal due August 27, 2031.
Revolver and accordion borrowings bear interest at the greater of 5.00% or one-month term SOFR plus a margin initially set at 2.50%.
An accordion option allows up to $3.5 million for one 120-day period each fiscal year, subject to a 0.50% origination fee.
Cineverse's subsidiary Cineverse Pans LLC entered a loan agreement with BondIt LLC for a term loan of up to $3,125,000, maturing October 26, 2027, with the proceeds used partly to repay advances to the film licensor, fund a 3D conversion, and pay down part of the company's East West Bank credit facility. The loan is secured by the film and its distribution proceeds, and Cineverse guaranteed it up to $2,343,750, a guarantee subordinated to the East West Bank facility, which adds a new debt obligation for shareholders to weigh.
Principal of up to $3,125,000 with a maturity date of October 26, 2027.
Minimum interest of $179,000 applies through the seven-month period after closing; thereafter, monthly interest of 1.39%.
Lender receives an 11.25% royalty on specified film receipts until it has received up to 1.75 times principal and interest paid.
Company guarantee capped at $2,343,750; agreements dated as of August 28, 2026, and entered August 31, 2026.
Arrow Electronics entered into Amendment No. 36 to its domestic accounts-receivable securitization facility on September 2, 2026. The amendment extends the maturity to September 2, 2029, and raises the facility limit from $1.5 billion to $1.75 billion, adding a temporary leverage ratio step-up for certain material acquisitions.
Maturity extended from September 10, 2027 to September 2, 2029
Facility limit increased from $1.5 billion to $1.75 billion
Step-up provision temporarily raises maximum permitted leverage ratio after certain material acquisitions
Six banks participate, including Bank of America, PNC Bank, Truist Bank, Wells Fargo Bank, Mizuho Bank and Sumitomo Mitsui Banking Corporation
NeoVolta entered a Loan, Security and Guaranty Agreement on September 4, 2026, under which lenders agreed to make term loans totaling $20 million, maturing March 3, 2028, with the company also issuing five-year warrants to the lenders. The loans are secured by a first priority interest in substantially all company assets and carry covenants, including a minimum cash requirement, so the financing adds debt and potential share dilution for shareholders.
Term loans total $20 million at 10.00% annual interest, with a scheduled maturity of March 3, 2028, and proceeds limited to working capital and general corporate purposes.
Amortization payments begin December 4, 2026, equal to the greater of $1.25 million or 7.5% of the prior month's traded value, capped at $2 million per payment.
Five-year warrants for 1,454,545 shares at $3.30 per share were issued, with up to 727,273 more warrant shares possible if the loan increases by up to $10 million.
Loans are secured by substantially all company and subsidiary assets and require at least $5 million of cash on hand at all times.
On September 4, 2026, Intellia Therapeutics entered a five-year senior secured credit agreement with OrbiMed that provides up to $400 million, with $75 million drawn at closing. The remaining $325 million is available in tranches tied to FDA approval of lonvo-z, revenue targets and an equity fundraising target, plus an uncommitted $100 million that requires mutual agreement. The debt adds to Intellia's obligations, carries a floating-rate interest cost and is secured by substantially all of the company's assets, including its intellectual property.
$75 million funded at closing on September 4, 2026; up to $325 million more available subject to milestones
Loans bear interest at the greater of 3.00% or one-month SOFR plus 6.15%, and mature September 4, 2031
Obligations secured on a first-priority basis by substantially all assets, including intellectual property
Covenants require at least $50 million of liquidity in controlled accounts until FDA approves the lonvo-z BLA
Three Lions Acquisition Corp., a blank check company, closed its initial public offering on September 2, 2026, selling 10,000,000 units at $10.00 each for $100,000,000 in gross proceeds. The company has no operating business, and $100,500,000 from the offering and a concurrent private placement is held in trust, to be released only upon completion of an initial business combination or redemption of public shares. Shareholders should note the company must complete a business combination within 21 months of the offering closing, or extend that deadline with shareholder approval.
Sold 10,000,000 units at $10.00 each, for $100,000,000 in gross proceeds, closing September 2, 2026
$100,500,000 of offering and private placement proceeds placed in the trust account, with Continental as trustee
Private placement of 400,000 units for $4,000,000 to the sponsor, EarlyBirdCapital and third-party investors on September 2, 2026
Units trade on Nasdaq as TLACU; EarlyBirdCapital holds a 45-day option for up to 1,500,000 additional units
Sysco signed a First Amendment to its revolving credit agreement creating a $750 million senior unsecured delayed draw term loan from CoBank, ACB, with proceeds to help pay cash consideration for its proposed JRD Unico and Warehouse Realty acquisition. The filing also sets one-time performance share unit and cash awards for executives tied to the closing of that acquisition, which is expected by the third quarter of 2027.
Term loan consists of a $375 million six-year tranche and a $375 million eight-year tranche, drawable over one year after the amendment's effective date
Loans will fund part of the cash consideration for the JRD Acquisition and related fees and expenses
CEO Kevin P. Hourican receives PSUs valued at $2 million and Interim CFO Brandon E. Sewell receives PSUs valued at $1 million, contingent on the JRD closing
Chief Human Resources Officer Ronald L. Phillips receives a $700,000 cash award, with 50% vesting September 4, 2026 and 50% on JRD closing
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.